NIAID is offering a grant opportunity for investigator-initiated Program Project (P01) applications focusing on areas related to microbes, immune system development, and immune dysfunction. Projects should aim to study HIV, immune function, autoimmunity, allergy, asthma, transplant rejection, and develop vaccines, therapeutics, and diagnostics. Applicants must include at least two related research projects with a common theme. Closing date for submissions is September 7, 2022.
Opportunity ID: 322954
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-20-072 |
Funding Opportunity Title: | NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 09, 2019 |
Last Updated Date: | Dec 09, 2019 |
Original Closing Date for Applications: | Sep 07, 2022 |
Current Closing Date for Applications: | Sep 07, 2022 |
Archive Date: | Oct 13, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments Small businesses Native American tribal governments (Federally recognized) For profit organizations other than small businesses Special district governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments City or township governments Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function system development and function; and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases. Each P01 application submitted to this FOA must include at least two related research projects that share a common central theme, focus, and/or overall objective. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-072.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 322954 Full Announcement-PAR-20-072 -> PAR-20-072-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00258978 | Dec 09, 2019 | Jan 24, 2022 | View | |
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00257059 | Dec 09, 2019 | May 24, 2020 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269920 | Oct 29, 2021 | Sep 07, 2022 | View |
Package 1
Mandatory forms
322954 RR_SF424_2_0-2.0.pdf
322954 PHS398_CoverPageSupplement_5_0-5.0.pdf
322954 RR_OtherProjectInfo_1_4-1.4.pdf
322954 PerformanceSite_2_0-2.0.pdf
322954 RR_KeyPersonExpanded_2_0-2.0.pdf
322954 PHS398_ResearchPlan_4_0-4.0.pdf
322954 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
322954 PHS_Additional_IndirectCosts-1.0.pdf
322954 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
322954 RR_SF424_2_0-2.0.pdf
322954 PHS398_CoverPageSupplement_4_0-4.0.pdf
322954 RR_OtherProjectInfo_1_4-1.4.pdf
322954 PerformanceSite_2_0-2.0.pdf
322954 RR_KeyPersonExpanded_2_0-2.0.pdf
322954 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
322954 PHS_Additional_IndirectCosts-1.0.pdf
322954 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
322954 RR_SF424_5_0-5.0.pdf
322954 PHS398_CoverPageSupplement_5_0-5.0.pdf
322954 RR_OtherProjectInfo_1_4-1.4.pdf
322954 PerformanceSite_4_0-4.0.pdf
322954 RR_KeyPersonExpanded_4_0-4.0.pdf
322954 PHS398_ResearchPlan_4_0-4.0.pdf
322954 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
322954 PHS_Additional_IndirectCosts_2_0-2.0.pdf
322954 PHS_AssignmentRequestForm_3_0-3.0.pdf